218 related articles for article (PubMed ID: 29871587)
1. Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line.
Wong KE; Mora MC; Sultana N; Moriarty KP; Arenas RB; Yadava N; Schneider SS; Tirabassi MV
Tumour Biol; 2018 Jun; 40(6):1010428318779515. PubMed ID: 29871587
[TBL] [Abstract][Full Text] [Related]
2. Rhodiola crenulata inhibits Wnt/β-catenin signaling in glioblastoma.
Mora MC; Bassa LM; Wong KE; Tirabassi MV; Arenas RB; Schneider SS
J Surg Res; 2015 Aug; 197(2):247-55. PubMed ID: 25998182
[TBL] [Abstract][Full Text] [Related]
3. Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells.
Bassa LM; Jacobs C; Gregory K; Henchey E; Ser-Dolansky J; Schneider SS
Phytomedicine; 2016 Jan; 23(1):87-94. PubMed ID: 26850689
[TBL] [Abstract][Full Text] [Related]
4. Potential anti-neuroblastoma agents from Juniperus oblonga.
Qiao Y; Sunada NK; Hatada AE; Lange I; Khutsishvili M; Alizade V; Atha D; Ko'omoa-Lange DL; Borris RP
Biochem Biophys Res Commun; 2019 Aug; 516(3):733-738. PubMed ID: 31255282
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.
Dudek MC; Wong KE; Bassa LM; Mora MC; Ser-Dolansky J; Henneberry JM; Crisi GM; Arenas RB; Schneider SS
Tumour Biol; 2015 Dec; 36(12):9795-805. PubMed ID: 26159852
[TBL] [Abstract][Full Text] [Related]
6. Rhodiola crenulata induces death and inhibits growth of breast cancer cell lines.
Tu Y; Roberts L; Shetty K; Schneider SS
J Med Food; 2008 Sep; 11(3):413-23. PubMed ID: 18800886
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth.
Chuang JH; Chou MH; Tai MH; Lin TK; Liou CW; Chen T; Hsu WM; Wang PW
Int J Biochem Cell Biol; 2013 May; 45(5):944-51. PubMed ID: 23395630
[TBL] [Abstract][Full Text] [Related]
10. Druggable epigenetic suppression of interferon-induced chemokine expression linked to
Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
[TBL] [Abstract][Full Text] [Related]
12. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
[TBL] [Abstract][Full Text] [Related]
13. MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma.
Guan J; Li M; Wang Y; Zhang Y; Que Y; Lu S; Wang J; Zhu J; Huang J; Zhen Z; Sun F; Song M; Zhang Y
Cell Death Dis; 2024 Feb; 15(2):124. PubMed ID: 38336749
[TBL] [Abstract][Full Text] [Related]
14.
Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.
Kunnimalaiyaan S; Schwartz VK; Jackson IA; Clark Gamblin T; Kunnimalaiyaan M
BMC Cancer; 2018 May; 18(1):560. PubMed ID: 29751783
[TBL] [Abstract][Full Text] [Related]
16. Rhodiola crenulata attenuates apoptosis and mitochondrial energy metabolism disorder in rats with hypobaric hypoxia-induced brain injury by regulating the HIF-1α/microRNA 210/ISCU1/2(COX10) signaling pathway.
Wang X; Hou Y; Li Q; Li X; Wang W; Ai X; Kuang T; Chen X; Zhang Y; Zhang J; Hu Y; Meng X
J Ethnopharmacol; 2019 Sep; 241():111801. PubMed ID: 30878546
[TBL] [Abstract][Full Text] [Related]
17. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
18.
Maeshima R; Moulding D; Stoker AW; Hart SL
Nucleic Acid Ther; 2020 Aug; 30(4):237-248. PubMed ID: 32240058
[TBL] [Abstract][Full Text] [Related]
19. MYCN and HIF-1 directly regulate
Hains AE; Uppal S; Cao JZ; Salwen HR; Applebaum MA; Cohn SL; Godley LA
Epigenetics; 2022 Dec; 17(13):2056-2074. PubMed ID: 35942521
[TBL] [Abstract][Full Text] [Related]
20. Rhodiola crenulata Attenuates High Glucose Induced Endothelial Dysfunction in Human Umbilical Vein Endothelial Cells.
Huang LY; Yen IC; Tsai WC; Ahmetaj-Shala B; Chang TC; Tsai CS; Lee SY
Am J Chin Med; 2017; 45(6):1201-1216. PubMed ID: 28830211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
